| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Neurology, Cell Biology, and Neurochemistry Laboratories [U. B., R. A., M. G., C. B., R. M.], Institute of Genetics and Microbiology [C. B.], and Institute of Physiological Chemistry [J. H.], Julius-Maximilians-University, Würzburg, Josef-Schneider Strasse 11, D 8700 Federal Republic of Germany
Autocrine-secreted tumor cell growth-inhibiting activities were isolated from supernatants of a malignant melanoma cell line, HTZ 19-dM, established from a central nervous system melanoma metastasis. HTZ 19-dM was characterized by cyto- and immunocytochemistry and karyotyping; cells were propagated in defined serum-free tissue culture medium for up to 8 months. Supernatants were ultrafiltrated, dialyzed, lyophilized, and purified by Bio-Gel P-10 gel permeation chromatography, leading to three active fraction pools, MIAI [melanoma-inhibiting activity (MIA), 2 kDa), MIAII (Mr 11,50017,000) and MIAIII (proteins at the cutoff of Bio-Gel P-10) inhibiting growth of 19-dM cells with 50% inhibitory concentrations of 0.79 µg/ml (MIAI), 0.13 µg/ml (MIAII), and 16.7 µg/ml (MIAII). MIAII could be further purified by reverse phase high pressure liquid chromatography; the main activity displayed a 50% inhibitory concentration of 0.33 µg/ml. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis one major band (molecular weight about 14,000) and two minor bands (up to Mr 17,000) were identified. Macromolecular synthesis was inhibited in 19-dM cells up to >99.5%; tumor stem cell colony formation was reduced by 99.89%; the inhibitory effect of MIAII was irreversible, nonsaturable, and partially antagonized by a serum factor (depending on purification stage). MIAII was heat stable (3 min at 100°C) and trypsin labile. The effect of MIAII on allogeneic neuroectodermal tumors was also investigated; proliferation of two of three malignant melanomas and two of four glioblastomas was inhibited up to 85.2%; proliferation of a neuroblastoma cell line could be inhibited to 33.8%, whereas normal fibroblasts and low grade gliomas were not influenced in their proliferation.
1 To whom requests for reprints should be addressed.
Received 3/ 9/89. Revised 6/22/89. Accepted 7/ 6/89.
This article has been cited by other articles:
![]() |
M. B. Faries, R. K. Gupta, X. Ye, E. C. Hsueh, and D. L. Morton Melanoma-Inhibiting Activity Assay Predicts Survival in Patients Receiving a Therapeutic Cancer Vaccine After Complete Resection of American Joint Committee on Cancer Stage III Melanoma Ann. Surg. Oncol., January 1, 2004; 11(1): 85 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Bosserhoff, M. Moser, J. Scholmerich, R. Buettner, and C. Hellerbrand Specific Expression and Regulation of the New Melanoma Inhibitory Activity-related Gene MIA2 in Hepatocytes J. Biol. Chem., April 18, 2003; 278(17): 15225 - 15231. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stoll, C. Renner, R. Buettner, W. Voelter, A.-K. Bosserhoff, and T. A. Holak Backbone dynamics of the human MIA protein studied by 15N NMR relaxation: Implications for extended interactions of SH3 domains Protein Sci., March 1, 2003; 12(3): 510 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Deichmann, A. Benner, M. Bock, A. Jackel, K. Uhl, V. Waldmann, and H. Naher S100-Beta, Melanoma-Inhibiting Activity, and Lactate Dehydrogenase Discriminate Progressive From Nonprogressive American Joint Committee on Cancer Stage IV Melanoma J. Clin. Oncol., June 1, 1999; 17(6): 1891 - 1891. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-F. Xie, S. Kondo, and L. J. Sandell Regulation of the Mouse Cartilage-derived Retinoic Acid-sensitive Protein Gene by the Transcription Factor AP-2 J. Biol. Chem., February 27, 1998; 273(9): 5026 - 5032. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Bosserhoff, Rüd. Hein, U. Bogdahn, and R. Buettner Structure and Promoter Analysis of the Gene Encoding the Human Melanoma-inhibiting Protein MIA J. Biol. Chem., January 5, 1996; 271(1): 490 - 495. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |